SUN:ASXSuncorp Group Limited Analysis
Data as of 2026-05-24 - not real-time
A$17.51
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
The 20‑day simple moving average sits just above the 50‑day SMA, while the 200‑day SMA remains higher than the current trading level, suggesting a short‑term upward bias within a longer‑term neutral backdrop. RSI is in the low‑60s, indicating solid momentum without reaching overbought territory. MACD shows a bullish histogram and the signal line is below the MACD line, reinforcing positive price pressure. The stock’s beta is well below one, pointing to low sensitivity to broader market swings, and 30‑day volatility near the low‑20% range suggests moderate price swings. However, the price‑to‑earnings multiple sits above the industry average, implying a premium valuation at present.
Analyst sentiment leans toward a buy, with a target price modestly above the current level, while the dividend payout ratio exceeds 100%, raising questions about sustainability. The DCF‑derived fair value is markedly higher than today’s price, indicating potential upside if cash‑flow assumptions hold. Increasing volume trends support the technical bullish signals, but regulatory and insurance‑specific risks remain a consideration. Overall, the blend of technical strength, modest growth prospects, and valuation nuances points to a cautiously optimistic outlook.
Analyst sentiment leans toward a buy, with a target price modestly above the current level, while the dividend payout ratio exceeds 100%, raising questions about sustainability. The DCF‑derived fair value is markedly higher than today’s price, indicating potential upside if cash‑flow assumptions hold. Increasing volume trends support the technical bullish signals, but regulatory and insurance‑specific risks remain a consideration. Overall, the blend of technical strength, modest growth prospects, and valuation nuances points to a cautiously optimistic outlook.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD crossover with positive histogram
- RSI indicating strong but not overbought momentum
- Increasing volume supporting upward price pressure
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Modest revenue and earnings growth expectations
- Current price near analyst target median
- Dividend payout ratio above 100% creating sustainability concerns
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value suggests meaningful upside
- Low beta and stable cash‑flow generation from insurance operations
- Solid balance sheet with manageable leverage
Key Metrics & Analysis
Financial Health
Revenue Growth1.70%
Profit Margin6.54%
P/E Ratio21.1
ROE8.40%
ROA2.83%
Debt/Equity22.54
P/B Ratio1.9
Op. Cash FlowA$1.7B
Free Cash FlowA$2.3B
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI61.6
SupportA$16.46
ResistanceA$17.83
MA 20A$17.13
MA 50A$16.54
MA 200A$17.99
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61
Valuation
Fair ValueA$29.06
Target PriceA$18.73
Upside/Downside6.98%
GradeFair
TypeBlend
Dividend Yield1.94%
Risk Assessment
Beta0.18
Volatility20.97%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.